Skip to main navigation Skip to search Skip to main content

SAHMRI Research Showcase

    Activity: Invited talks and oral presentations › Oral conference presentations and other invited talks

    Description

    Eadie LN, Schutz CE, Page EC, Lagonik E, Forgione MO, Rehn JA, Hughes TP, Yeung DT, White DL
    Asciminib is a novel targeted inhibitor of the NUP214::ABL1 fusion gene in B-cell and T-cell acute lymphoblastic leukaemia
    Oral Presentation
    Adelaide, South Australia
    Period15 Nov 2022 → 16 Nov 2022
    Event titleSAHMRI Research Showcase
    Event typeConference
    LocationAustraliaShow on map
    Degree of RecognitionLocal